Update Status of the BRITE Database


IDBrite hierarchyLast update
00001KEGG Orthology (KO)08-8-20
00002KEGG pathway modules08-1-1
00194Photosynthesis proteins06-9-28
00199Cytochrome P45006-6-5
00535Proteoglycans06-3-10
01000Enzymes08-8-15
01001Protein kinases07-8-9
01002Peptidases08-7-7
01003Glycosyltransferases08-7-22
02000Transporters08-8-4
02022Two-component system08-1-25
02035Bacterial motility proteins06-6-6
03000Transcription factors08-7-3
03011Ribosome05-10-28
03012Translation factors04-9-3
03032DNA replication proteins08-3-18
03110Chaperones and folding catalysts07-7-23
04000Receptors and channels07-7-9
04031GTP-binding proteins07-2-13
04052Cytokines07-7-2
04090Cellular antigens08-7-17
04091Glycan binding proteins07-7-23
04121Ubiquitin system08-1-8
04131SNAREs06-7-11
04515Cell adhesion molecules (CAMs)05-7-20
04516CAM ligands05-7-20
04812Cytoskeleton proteins07-10-24
08001Compounds with biological roles06-7-4
08002Lipids08-4-21
08003Phytochemical compounds07-4-19
08004Polyketides and nonribosomal peptides08-7-7
08005Bioactive peptides07-5-30
08101Enzyme ligands08-7-8
08102Transporter substrates08-7-1
08103Ion channel ligands08-5-8
08104GPCR ligands07-8-7
08105Cytochrome P450 substrates06-2-7
08106Nuclear receptor ligands06-9-29
08201IUBMB reactions08-7-15
08202IUBMB reaction hierarchy08-7-15
08203Glycosyltransferase reactions08-7-22
08301Therapeutic category of drugs08-8-13
08302USP drug classification08-7-1
08303ATC classification08-8-8
08304TCM drugs in Japan08-5-13
08311Japanese Pharmacopoeia08-1-9
08401Pathogens and infectious diseases08-3-25
08402Human diseases08-3-18
08403ICD-10 disease classification08-3-25
08601KEGG organisms08-8-19
08901KEGG pathway maps08-8-4


Last updated: August 20, 2008
Back to KEGG table of contents